Toll-Like Receptor 9 in Breast Cancer

por Sandholm, Jouko, Selander, Katri S.
Publicado 2014

Toll-Like Receptors in Esophageal Cancer

por Kauppila, Joonas H., Selander, Katri S.
Publicado 2014

A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma

por Jamil, Muhammad Omer, Jerome, Mary S, Miley, Deborah, Selander, Katri S, Robert, Francisco
Publicado 2017

Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer

por VÄISÄNEN, MARJA-RIITTA, JUKKOLA-VUORINEN, ARJA, VUOPALA, KATRI S., SELANDER, KATRI S., VAARALA, MARKKU H.
Publicado 2013

Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer

por TUOMELA, JOHANNA, SANDHOLM, JOUKO, KAUPPILA, JOONAS H., LEHENKARI, PETRI, HARRIS, KEVIN W., SELANDER, KATRI S.
Publicado 2013

Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro

por SANDHOLM, JOUKO, TUOMELA, JOHANNA, KAUPPILA, JOONAS H., HARRIS, KEVIN W., GRAVES, DAVID, SELANDER, KATRI S.
Publicado 2014

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

por Ronkainen, Hanna, Hirvikoski, Pasi, Kauppila, Saila, Vuopala, Katri S, Paavonen, Timo K, Selander, Katri S, Vaarala, Markku H
Publicado 2011

CD73 regulates zoledronate-induced lymphocyte infiltration in triple-negative breast cancer tumors and lung metastases

por Petruk, Nataliia, Siddiqui, Arafat, Tadayon, Sina, Määttä, Jorma, Mattila, Pieta K., Jukkola, Arja, Sandholm, Jouko, Selander, Katri S.
Publicado 2023

Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas

por Karihtala, Peeter, Porvari, Katja, Roininen, Nelli, Voutilainen, Sari, Mattson, Johanna, Heikkilä, Päivi, Haapasaari, Kirsi-Maria, Selander, Katri
Publicado 2022

CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer

por Petruk, Nataliia, Tuominen, Sanni, Åkerfelt, Malin, Mattsson, Jesse, Sandholm, Jouko, Nees, Matthias, Yegutkin, Gennady G., Jukkola, Arja, Tuomela, Johanna, Selander, Katri S.
Publicado 2021

Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans

por Chandler, Madison R., Keene, Kimberly S., Tuomela, Johanna M., Forero-Torres, Andres, Desmond, Renee, Vuopala, Katri S., Harris, Kevin W., Merner, Nancy D., Selander, Katri S.
Publicado 2017

Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo

por Sandholm, Jouko, Lehtimäki, Jaakko, Ishizu, Tamiko, Velu, Sadanandan E., Clark, Jeremy, Härkönen, Pirkko, Jukkola-Vuorinen, Arja, Schrey, Aleksi, Harris, Kevin W., Tuomela, Johanna M., Selander, Katri S.
Publicado 2016

Arming a Replicating Adenovirus with Osteoprotegerin Reduces the Tumor Burden in a Murine Model of Osteolytic Bone Metastases of Breast Cancer

por Cody, James J., Rivera, Angel A., Lyons, Gray R., Yang, Sherry W., Wang, Minghui, Sarver, David B., Wang, Dezhi, Selander, Katri S., Kuo, Hui-Chien, Meleth, Sreelatha, Feng, Xu, Siegal, Gene P., Douglas, Joanne T.
Publicado 2010